Xtant Medical Holdings, Inc.
XTNT
$0.51
$0.036.25%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 12.11% | 11.66% | 48.00% | 55.34% | 84.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.11% | 11.66% | 48.00% | 55.34% | 84.07% |
| Cost of Revenue | 41.18% | 20.08% | 46.16% | 42.72% | 57.54% |
| Gross Profit | -6.49% | 6.35% | 49.15% | 64.22% | 106.32% |
| SG&A Expenses | -15.00% | 6.33% | 52.83% | 69.58% | 108.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.64% | 11.65% | 52.10% | 60.58% | 87.80% |
| Operating Income | 50.55% | -11.58% | -111.79% | -120.18% | -120.77% |
| Income Before Tax | 15.62% | -171.59% | -75.70% | -109.78% | -70.29% |
| Income Tax Expenses | -96.36% | 102.70% | 176.92% | 423.08% | 2,647.62% |
| Earnings from Continuing Operations | 26.45% | -154.43% | -76.30% | -111.74% | -94.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 26.45% | -154.43% | -76.30% | -111.74% | -94.79% |
| EBIT | 50.55% | -11.58% | -111.79% | -120.18% | -120.77% |
| EBITDA | 73.68% | -8.07% | -231.29% | -123.08% | -98.79% |
| EPS Basic | 39.58% | -151.67% | -47.26% | -76.96% | -62.25% |
| Normalized Basic EPS | 41.23% | -15.00% | -47.20% | -74.79% | -67.46% |
| EPS Diluted | 39.58% | -157.14% | -49.25% | -69.00% | -61.46% |
| Normalized Diluted EPS | 41.23% | -21.69% | -47.20% | -74.79% | -67.46% |
| Average Basic Shares Outstanding | 21.71% | 5.43% | 19.63% | 19.57% | 20.01% |
| Average Diluted Shares Outstanding | 21.71% | -0.42% | 19.63% | 19.57% | 20.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |